ProSciento Closes Growth Financing from 1315 Capital Read More »
ProSciento Appoints Stephen Mullennix as Chief Financial Officer Read More »
View Recent Webinar
Customized Programs for Clinical Development and Global Regulatory Services Read More »
184 Insulin Sensitivity and Glucose Metabolism of Olanzapine and Combination Olanzapine and Samidorphan: A Phase 1 Exploratory Study in Healthy Volunteers Read More »
Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »
